Investor News
Detailing the news for investors with regards to Microvisk's development.
- Microvisk Technologies is pleased to announce that it has raised £2m by attracting new investors and retaining support from its current private and institutional investors.
- John Curtis, CEO of Microvisk, said:
"We are extremely pleased that in such a difficult capital market, the fundamental advantages of the Microvisk technology and product in development has been recognised by our new investors and that our current investors have continued to support our product development in a time when the alternative investment opportunities are so numerous." - Read the full Press Release for further information.
- The development program is now focused on the completion of simple hand held instruments with disposable plastic test strips for the measurement of Prothrombin Time; both in the Doctor’s office and the home testing environments.
- The 2007 funding enabled Microvisk to expand into new premises in St Asaph and Chipping Warden, providing the space and resources for future expansion and to assist the further development of the technologies and applications.
- The 2006 funding enabled Microvisk to conduct a trial at St Bartholomew's Hospital Group in London with assistance from Professor John Pasi, Professor of Haemostasis and Thrombosis and the results were spectacular in regards of the performance of our prototype when compared to systems already on the market.
- Microvisk was formed in 2004 as a spin out from Rutherford Appleton Laboratories with its first patent being filed in December 2003.
What's next?
Contact us for more information on 0845 956 9900 or why not make an enquiry and we'll be in touch shortly.
